Loading clinical trials...
Loading clinical trials...
To compare different timing of insulin Glargine administration (early-6 pm versus standard bedtime-10 pm) as part of standard of care in patients with type1 diabetes who wish to fast the month of Rama...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
King Abdullah International Medical Research Center
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT06881992 · Tumor Hyperinsulinism (Tumor HI)
NCT07585032 · Insulinoma; Pancreas
NCT02861781 · Obesity, Insulin Resistance, and more
NCT04205604 · Congenital Hyperinsulinism
KingAbullahIMRC
Jeddah
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions